U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07839039) titled 'A Pilot Study Comparison of Programmed Intermittent Bolus Versus Continuous Infusion' on S... Read More
U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07838272) titled 'Enhancing Emotion Regulation in Children With Autism Through Extended Reality' on Aug. 24.... Read More
U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07840118) titled 'Smartphone-based Incentives Intervention to Increase Smoking Cessation During Pregnancy' o... Read More
U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07839780) titled 'S-PRG Filler for Preventing White Spot Lesions During Orthodontic Treatment' on Sept. 17. ... Read More
U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07839221) titled 'Combined GDF-15 and Lung Ultrasound for Subclinical ILD Screening in Rheumatoid Arthritis ... Read More
U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07838636) titled 'Effect of Physical Activity on the Course of Parkinson's Disease in Patients With Bilatera... Read More
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'Evaluating the Year-Round Immunogenicity of Standard-Dose Versus High-Dose Seasonal Influenza Vac... Read More
U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07839897) titled 'EFFICACY AND TOLERANCE OF AN EMOLLIENT CREAM IN SKIN OF COLOR' on Sept. 18. Brief Summary... Read More
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'Beamion LUNG-1: An open label, Phase I dose escalation trial, with dose confirmation and expansio... Read More
Singapore, Sept. 25 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutam... Read More